ABBV - AbbVie Inc.
184.6
-0.980 -0.531%
Share volume: 7,806,372
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$185.58
-0.98
-0.01%
Summary score
73%
Profitability
71%
Dept financing
50%
Liquidity
43%
Performance
88%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
18.48%
Return on assets
2.05%
Return on sales
26.18%
Return on invested capital
3.03%
Total debt ratio
92.05%
Debt ratio change over timeo
44.32%
Current Ratio
0.86%
Quick Ratio
0.75%
Cash Position Ratio
0.28%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
1.05%
Return on sales
18.06%
Return on invested capital
0%
Total debt ratio
96.88%
Debt ratio change over timeo
0%
Current Ratio
0.72%
Quick Ratio
0.61%
Cash Position Ratio
0.19%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
1.68%
Return on sales
27.98%
Return on invested capital
0%
Total debt ratio
98.96%
Debt ratio change over time
0%
Current Ratio
0.76%
Quick Ratio
0.64%
Cash Position Ratio
0.14%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
1171.75%
Return on assets
75.16%
Return on sales
1683.18%
Return on invested capital
97.09%
Total debt ratio
4432.21%
Debt ratio change over time
44.32%
Current Ratio
46.46%
Quick Ratio
41.12%
Cash Position Ratio
17.31%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ABBV | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 18.48% | 14.28% | 9.23% | 0% |
| Return on assets | 2.05% | 4.23% | 3.2% | 0% |
| Return on sales | 26.18% | 27.89% | 25.03% | 0% |
| Return on invested capital | 3.03% | 8.36% | 9.37% | 0% |
| Profitability | 69% | 92% | 79% | 0% |
| Total debt ratio | 92.05% | 81.28% | 59.58% | 0% |
| Debt ratio change over time | 44.32% | -11.36% | -57.43% | 0% |
| Dept financing | 50% | 22% | 16% | 0% |
| Current Ratio | 0.72% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0.61% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 0.19% | 0.12% | 0.5% | 0% |
| Liquididy | 49% | 55% | 75% | 0% |
| Short-term ratios | ABBV | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 1.05% | 4.32% | 3.49% | 0% |
| Return on sales | 18.06% | 28.32% | 23.63% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 72% | 50% | 41% | 0% |
| Total debt ratio | 96.88% | 81.66% | 60.28% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 21% | 16% | 0% |
| Current Ratio | 0.72% | 1.23% | 1.12% | 0% |
| Quick Ratio | 0.61% | 0.95% | 0.88% | 0% |
| Cash Position Ratio | 0.19% | 0.12% | 0.5% | 0% |
| Liquididy | 40% | 56% | 71% | 0% |
